NIH: Condition of US patient being treated for Ebola improves

According to physicians from the National Institutes of Health Clinical Center in Bethesda, Md., the condition of the U.S. patient with Ebola virus disease has improved from critical to serious.

Advertisement

No additional details about the patient were released.

The NIH also announced the Ebola virus circulating in West Africa has undergone relatively few mutations that would make it more severe or transmissible.

“The Ebola virus in the ongoing West African outbreak appears to be stable — that is, it does not appear to be mutating more rapidly than viruses in previous Ebola outbreaks, and that is reassuring,” said Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases branch of NIH.

 

 

More articles on Ebola:
15 recent stories on Ebola
Possible Ebola patient taken to LA-area hospital
FDA advisory committee to meet on Ebola vaccines in May

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.